SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-21-000013
Filing Date
2021-02-22
Accepted
2021-02-22 08:34:34
Documents
3
Period of Report
2021-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K awh-20210222x8k.htm 8-K 36532
2 EX-99.1 awh-20210222xex99_1.htm EX-99.1 12747
3 GRAPHIC awh-20210222xex99_1g001.jpg GRAPHIC 5854
  Complete submission text file 0000926617-21-000013.txt   59117
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 21658351
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences